Connection

Antonio Gasbarrini to Drug Synergism

This is a "connection" page, showing publications Antonio Gasbarrini has written about Drug Synergism.
Connection Strength

0.180
  1. The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease. Expert Opin Investig Drugs. 2018 06; 27(6):543-551.
    View in: PubMed
    Score: 0.142
  2. Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy. Eur Rev Med Pharmacol Sci. 2019 Jul; 23(14):6379-6386.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.